---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-007404"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T04:46:22.139487+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma subleases 22,909 sq ft of manufacturing facility to AMTMS; to expand to entire facility by Dec 2024

## Summary
- Subleases 22,909 sq ft (~30%) of Grand Prairie, TX facility to AMTMS; base rent $20,045/mo through Dec 2023, then $21,000/mo until expansion.
- Expansion to entire 77,112 sq ft facility by Dec 31, 2024; rent rises to $70,686/mo. Security deposit of $90,731.
- CEO says sublease reduces monthly operating expenses, supports margin improvement for ADHD products; longer-term plan to transfer manufacturing to contract manufacturer.
- AMTMS is a new CMO; will use facility for nutraceutical and pharmaceutical manufacturing.

## SEC filing metadata
- accession: 0001558370-23-007404
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000155837023007404/0001558370-23-007404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000155837023007404/aytu-20230427x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-007404
- JSON: https://secwatch.observer/filing/0001558370-23-007404.json
- Plain text: https://secwatch.observer/filing/0001558370-23-007404.txt

## Key facts
- Material Agreements
  AYTU BIOPHARMA, INC entered into Sublease Agreement with AMT Manufacturing Solutions, LLC (effective 2023-04-27).
  - Action: entry
  - Agreement: lease
  - Counterparty: AMT Manufacturing Solutions, LLC
  - Effective: 2023-04-27
  source text: On April 27, 2023, Aytu BioPharma, Inc., through its wholly-owned subsidiary, Neos Therapeutics, LP, (“Aytu” or the “Company”) and AMT Manufacturing Solutions, LLC (“AMTMS”) entered into an agreement for Aytu to sublease 22,909 square feet of its manufacturing facility in Grand Prairie, Texas (“Sublease Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1385818/000155837023007404/0001558370-23-007404-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.